Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Index- P/E15.95 EPS (ttm)0.68 Insider Own0.95% Shs Outstand494.45M Perf Week4.95%
Market Cap5.35B Forward P/E11.20 EPS next Y0.97 Insider Trans0.97% Shs Float489.91M Perf Month-3.74%
Income338.00M PEG2.49 EPS next Q0.31 Inst Own99.74% Short Float2.95% Perf Quarter-10.87%
Sales4.44B P/S1.21 EPS this Y-9.06% Inst Trans-2.59% Short Ratio3.17 Perf Half Y-24.28%
Book/sh12.33 P/B0.88 EPS next Y16.73% ROA2.51% Short Interest14.46M Perf Year-31.43%
Cash/sh0.95 P/C11.44 EPS next 5Y6.41% ROE5.49% 52W Range10.03 - 18.80 Perf YTD-10.65%
Dividend Est.- P/FCF13.58 EPS past 5Y29.95% ROI3.23% 52W High-42.45% Beta1.44
Dividend TTM- Quick Ratio1.25 Sales past 5Y9.07% Gross Margin43.01% 52W Low7.88% ATR (14)0.40
Dividend Ex-Date- Current Ratio2.44 EPS Y/Y TTM127.38% Oper. Margin5.65% RSI (14)47.27 Volatility3.07% 3.83%
Employees9450 Debt/Eq0.73 Sales Y/Y TTM0.50% Profit Margin7.61% Recom1.88 Target Price15.67
Option/ShortYes / Yes LT Debt/Eq0.72 EPS Q/Q94.34% Payout0.00% Rel Volume0.30 Prev Close10.83
Sales Surprise1.10% EPS Surprise-6.04% Sales Q/Q-1.45% EarningsFeb 25 BMO Avg Volume4.56M Price10.82
SMA200.16% SMA50-4.93% SMA200-18.98% Trades Volume292,094 Change-0.09%
Date Action Analyst Rating Change Price Target Change
Dec-09-24Initiated UBS Buy $18
Dec-02-24Initiated Leerink Partners Market Perform $14
Sep-19-24Downgrade Morgan Stanley Overweight → Equal-Weight $17 → $15
Jan-05-24Upgrade Stifel Hold → Buy $13 → $20
Dec-19-23Initiated Jefferies Buy $17
Dec-15-23Upgrade Morgan Stanley Equal-Weight → Overweight $16
Dec-07-23Initiated Exane BNP Paribas Outperform $18
Apr-20-23Upgrade Barclays Equal Weight → Overweight $14
Aug-18-22Downgrade Morgan Stanley Overweight → Equal-Weight $37 → $22
Aug-16-22Downgrade JP Morgan Overweight → Neutral $28 → $24
Mar-19-25 10:27AM
Mar-18-25 05:01AM
Mar-17-25 04:17PM
Mar-14-25 05:03AM
Mar-13-25 08:44AM
11:05PM Loading…
Mar-11-25 11:05PM
Feb-26-25 06:09PM
02:05AM
12:34AM
Feb-25-25 01:38PM
01:15PM
09:30AM
08:20AM
07:15AM
07:05AM
07:05AM Loading…
07:05AM
Feb-24-25 09:16AM
08:05AM
Feb-21-25 08:00AM
Feb-20-25 12:05PM
08:27AM
Feb-13-25 04:29PM
Feb-10-25 12:17PM
Feb-04-25 08:00AM
Feb-03-25 12:18AM
Jan-30-25 02:45PM
Jan-27-25 08:06AM
Jan-23-25 08:27AM
Jan-12-25 09:38AM
Jan-10-25 12:30PM
11:07AM Loading…
Dec-19-24 11:07AM
Dec-01-24 09:08AM
Nov-29-24 12:18PM
Nov-27-24 01:45PM
Nov-26-24 07:22AM
04:31AM
Nov-25-24 08:45AM
08:00AM
Nov-24-24 11:33AM
Nov-23-24 07:23AM
Nov-21-24 10:46AM
Nov-20-24 08:53AM
Nov-18-24 02:52PM
Nov-15-24 11:30AM
Nov-14-24 03:15PM
Nov-13-24 01:39PM
Nov-12-24 07:20PM
08:33AM
05:45AM
Nov-11-24 04:02PM
Nov-08-24 04:03AM
02:09AM
02:03AM
Nov-07-24 04:30PM
03:28PM
12:41PM
09:30AM
08:52AM
07:35AM
06:27AM
Nov-05-24 07:38AM
Nov-04-24 03:51PM
09:16AM
Nov-01-24 05:45AM
Oct-31-24 01:42PM
10:01AM
Oct-30-24 11:46AM
Oct-28-24 07:17PM
Oct-25-24 09:56AM
Oct-24-24 02:29PM
Oct-23-24 10:16AM
Oct-22-24 10:42AM
Oct-21-24 06:12PM
Oct-17-24 12:14PM
12:10PM
Oct-16-24 11:21AM
08:54AM
Oct-11-24 09:14AM
Oct-10-24 08:00AM
Oct-09-24 11:23AM
Oct-08-24 08:43PM
Oct-07-24 04:19PM
Sep-20-24 10:35AM
Sep-19-24 03:08PM
01:42PM
12:50PM
Sep-13-24 07:30AM
Aug-28-24 06:30AM
Aug-20-24 06:27AM
Aug-15-24 08:27AM
Aug-13-24 01:49PM
Aug-09-24 02:35AM
Aug-08-24 03:45PM
09:30AM
07:35AM
06:28AM
Aug-06-24 01:00PM
Aug-05-24 09:16AM
Aug-01-24 03:14PM
10:01AM
Elanco Animal Health, Inc. innovates, develops, manufactures, and markets products for pets and farm animals. It offers products through the following four categories: Companion Animal Disease Prevention, Companion Animal Therapeutics, Food Animal Future Protein & Health, and Food Animal Ruminants & Swine. The Companion Animal Disease Prevention category engages in the broadest parasiticide portfolios in the companion animal sector based on indications, species and formulations, with products that protect pets from worms, fleas and ticks. The Companion Animal Therapeutics category provides the details of a broad pain and osteoarthritis portfolio across species, modes of action, indications and disease stages. The Food Animal Future Protein & Health category includes vaccines, nutritional enzymes and animal-only antibiotics, serves the growing demand for protein and includes innovative products in poultry and aquaculture production, where demand for animal health products is outpacing overall industry growth. It also focuses on developing functional nutritional health products that promote food animal health, including enzymes, probiotics and prebiotics. The Food Animal Ruminants & Swine category develops animal food products used in ruminant and swine production. The company was founded in 1954 and is headquartered in Greenfield, IN.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kurzius Lawrence ErikDirectorMar 07 '25Buy10.9010,000109,000101,459Mar 11 05:13 PM
Kurzius Lawrence ErikDirectorMar 11 '25Buy10.2010,000102,000111,459Mar 11 05:13 PM
HOOVER R DAVIDDirectorMar 05 '25Buy10.9025,000272,558210,000Mar 07 04:21 PM
Harrington Michael JDirectorAug 22 '24Buy14.853,50051,97481,094Aug 26 05:05 PM
Simmons Jeffrey NPRESIDENT, CEO AND DIRECTORAug 12 '24Buy13.01100,0001,300,610145,000Aug 13 09:04 AM
DOYLE WILLIAM FDirectorMay 21 '24Buy16.9815,000254,70076,330May 23 04:33 PM